Pulmonary infection by Yersinia pestis rapidly establishes a permissive environment for microbial proliferation

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 8, 2012, Pages 3083-3088

  Price, Paul A ^a,b   Jin, Jianping ^c   Goldman, William E ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Inflammation; Pathogenesis

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM MUTANT; EFFECTOR CELL; ENVIRONMENTAL FACTOR; HOST PATHOGEN INTERACTION; IMMUNOSUPPRESSIVE TREATMENT; LUNG INFECTION; MICROBIAL GROWTH; MOUSE; NONHUMAN; PRIORITY JOURNAL; YERSINIA PESTIS;

ANIMALS; GENETIC COMPLEMENTATION TEST; MICE; MICE, INBRED C57BL; MUTATION; PLAGUE; RESPIRATORY TRACT INFECTIONS; SUBCUTANEOUS TISSUE; TIME FACTORS; VIRULENCE; YERSINIA PESTIS;

EID: 84857407510     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1112729109     Document Type: Article

References (34)

1. Bubeck SS, Cantwell AM, Dube PH (2007) Delayed inflammatory response to primary pneumonic plague occurs in both outbred and inbred mice. Infect Immun 75:697-705. (Pubitemid 46203431)
2. Agar SL, et al. (2008) Characterization of a mouse model of plague after aerosolization of Yersinia pestis CO92. Microbiology 154(Pt 7):1939-1948.
3. Lathem WW, Crosby SD, Miller VL, Goldman WE (2005) Progression of primary pneumonic plague: A mouse model of infection, pathology, and bacterial transcriptional activity. Proc Natl Acad Sci USA 102:17786-17791. (Pubitemid 41803575)
4. Koster F, et al. (2010) Milestones in progression of primary pneumonic plague in cynomolgus macaques. Infect Immun 78:2946-2955.
5. Montminy SW, et al. (2006) Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response. Nat Immunol 7:1066-1073. (Pubitemid 44420651)
6. Lathem WW, Price PA, Miller VL, Goldman WE (2007) A plasminogen- activating protease specifically controls the development of primary pneumonic plague. Science 315:509-513. (Pubitemid 46175753)
7. Reithmeier-Rost D, et al. (2007) The weak interaction of LcrV and TLR2 does not contribute to the virulence of Yersinia pestis. Microbes Infect 9:997-1002. (Pubitemid 46929098)
8. Barton ES, et al. (2007) Herpesvirus latency confers symbiotic protection from bacterial infection. Nature 447:326-329. (Pubitemid 46788830)
9. Cantwell AM, Bubeck SS, Dube PH (2010) YopH inhibits early pro-inflammatory cytokine responses during plague pneumonia. BMC Immunol 11:29.
10. Lawrenz MB, Lenz JD,Miller VL (2009) A novel autotransporter adhesin is required for efficient colonization during bubonic plague. Infect Immun 77:317-326.
11. Huang X-Z, Nikolich MP, Lindler LE (2006) Current trends in plague research: From genomics to virulence. Clin Med Res 4:189-199. (Pubitemid 44496012)
12. Fisher ML, Castillo C, Mecsas J (2007) Intranasal inoculation of mice with Yersinia pseudotuberculosis causes a lethal lung infection that is dependent on Yersinia outer proteins and PhoP. Infect Immun 75:429-442. (Pubitemid 46047919)
13. Cornelis GR (2002) The Yersinia Ysc-Yop 'type III' weaponry. Nat Rev Mol Cell Biol 3:742-752.
14. Suzuki T, Chow C-W, Downey GP (2008) Role of innate immune cells and their products in lung immunopathology. Int J Biochem Cell Biol 40:1348-1361.
15. Ye Z, et al. (2011) Distinct CCR2(+) Gr1(+) cells control growth of the Yersinia pestis ΔyopM mutant in liver and spleen during systemic plague. Infect Immun 79:674-687.
16. Lawlor MS, Hsu J, Rick PD, Miller VL (2005) Identification of Klebsiella pneumoniae virulence determinants using an intranasal infection model. Mol Microbiol 58:1054-1073. (Pubitemid 41667225)
17. Chiang SL, Mekalanos JJ, Holden DW (1999) In vivo genetic analysis of bacterial virulence. Annu Rev Microbiol 53:129-154. (Pubitemid 29503728)
18. Sassetti CM, Rubin EJ (2003) Genetic requirements for mycobacterial survival during infection. Proc Natl Acad Sci USA 100:12989-12994. (Pubitemid 37340013)
19. Zhang S, et al. (2005) Comparative signature-tagged mutagenesis identifies Pseudomonas factors conferring resistance to the pulmonary collectin SP-A. PLoS Pathog 1:259-268.
20. Winstanley C, et al. (2009) Newly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool Epidemic Strain of Pseudomonas aeruginosa. Genome Res 19:12-23.
21. Cuccui J, et al. (2007) Development of signature-tagged mutagenesis in Burkholderia pseudomallei to identify genes important in survival and pathogenesis. Infect Immun 75:1186-1195. (Pubitemid 46385809)
22. Hunt TA, Kooi C, Sokol PA, Valvano MA (2004) Identification of Burkholderia cenocepacia genes required for bacterial survival in vivo. Infect Immun 72:4010-4022. (Pubitemid 38821916)
23. Hava DL, Camilli A (2002) Large-scale identification of serotype 4 Streptococcus pneumoniae virulence factors. Mol Microbiol 45:1389-1406.
24. Camacho LR, Ensergueix D, Perez E, Gicquel B, Guilhot C (1999) Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature-tagged transposon mutagenesis. Mol Microbiol 34:257-267. (Pubitemid 29486244)
25. Lorange EA, Race BL, Sebbane F, Joseph Hinnebusch B (2005) Poor vector competence of fleas and the evolution of hypervirulence in Yersinia pestis. J Infect Dis 191:1907-1912. (Pubitemid 40705399)
26. Datsenko KA, Wanner BL (2000) One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA 97:6640-6645. (Pubitemid 30412767)
27. Choi K-H, et al. (2005) A Tn7-based broad-range bacterial cloning and expression system. Nat Methods 2:443-448. (Pubitemid 40916563)
28. Sassetti CM, Boyd DH, Rubin EJ (2001) Comprehensive identification of conditionally essential genes in mycobacteria. Proc Natl Acad Sci USA 98:12712-12717. (Pubitemid 33020011)
29. Dennis JJ, Zylstra GJ (1998) Plasposons: Modular self-cloning minitransposon derivatives for rapid genetic analysis of Gram-negative bacterial genomes. Appl Environ Microbiol 64:2710-2715. (Pubitemid 28303324)
30. Sassetti CM, Boyd DH, Rubin EJ (2003) Genes required for mycobacterial growth defined by high density mutagenesis. Mol Microbiol 48:77-84. (Pubitemid 36411469)
31. Bubeck SS, Dube PH (2007) Yersinia pestis CO92 delta yopH is a potent live, attenuated plague vaccine. Clin Vaccine Immunol 14:1235-1238. (Pubitemid 47518094)
32. Perry RD, Fetherston JD (1997) Yersinia pestis-Etiologic agent of plague. Clin Microbiol Rev 10:35-66.
33. Kolodziejek AM, et al. (2010) Outer membrane protein X (Ail) contributes to Yersinia pestis virulence in pneumonic plague and its activity is dependent on the lipopolysaccharide core length. Infect Immun 78:5233-5243.
34. Fetherston JD, Kirillina O, Bobrov AG, Paulley JT, Perry RD (2010) The yersiniabactin transport system is critical for the pathogenesis of bubonic and pneumonic plague. Infect Immun 78:2045-2052.